StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical operating margin

Operating margin is operating income as a percentage of revenue.

VitaSpring Biomedical's operating margin for the twelve months ending Oct 31, 2022 was 28.2%. For fiscal 2022 it was 20.1%, against 171.4% the year before. The highest annual figure on record is 171.4% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Jan 31, 202220.1%−151.3
FY2021Jan 31, 2021171.4%+125.7
FY2020Jan 31, 202045.7%+176.1
FY2019Jan 31, 2019-130.4%−91.1
FY2018Jan 31, 2018-39.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2023CQ1 2022Apr 30, 202223.0%−10.6
Q4 FY2022CQ4 2021Jan 31, 202240.7%−187.2
Q3 FY2022CQ3 2021Oct 31, 202168.7%+974.8
Q2 FY2022CQ2 2021Jul 31, 202118.0%+136.0
Q1 FY2022CQ1 2021Apr 30, 202133.6%−6.4
Q4 FY2021CQ4 2020Jan 31, 2021227.9%–
Q4 FY2020CQ4 2019Jan 31, 2020-906.0%–
Q1 FY2020CQ1 2019Apr 30, 2019-117.9%–
Q1 FY2019CQ1 2018Apr 30, 201840.0%–

More VitaSpring Biomedical figures

See a number that looks wrong?